Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Tranexamic Acid (TXA) in Reducing Blood Loss in Hip Fracture Surgery

NCT02736383 is registered in ClinicalTrials.gov with Corewell Health West as lead sponsor.

NCT NCT02736383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02736383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Tranexamic Acid (TXA) in Reducing Blood Loss in Hip Fracture Surgery
Lead sponsor
Corewell Health West
Phase
Observational
Overall status
Completed
Start date
May 31, 2016
Completion date
July 31, 2017
Enrollment
142 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hip fracture